T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.64% |
| 2 | Consumer Discretionary | 13.46% |
| 3 | Financials | 12.79% |
| 4 | Industrials | 12.13% |
| 5 | Technology | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
THR
1101
DELISTED
Thermon Group Holdings
THR
| $21.8M | ﹤0.01% |
827,000
-2,760
| -0.3% | -$67.4K |
|
|
CVT
1102
DELISTED
CVENT, INC.
CVT
| $21.7M | ﹤0.01% |
745,294
+363,778
| +95% | +$10.3M |
|
1103
DTE Energy
DTE
$28.9B
| $21.6M | ﹤0.01% |
326,634
-13,982
| -4% | -$907K |
|
|
FDO
1104
DELISTED
FAMILY DOLLAR STORES
FDO
| $21.4M | ﹤0.01% |
324,304
-160,259
| -33% | -$9.66M |
|
|
BBBY
1105
DELISTED
Bed Bath & Beyond Inc
BBBY
| $20.9M | ﹤0.01% |
364,048
-13,130
| -3% | -$819K |
|
1106
Clearway Energy Class C
CWEN
$7.06B
| $20.9M | ﹤0.01% |
802,500
-101,000
| -11% | -$2.31M |
|
1107
F5
FFIV
$24B
| $20.8M | ﹤0.01% |
186,715
-10,200
| -5% | -$1.1M |
|
1108
Eastman Chemical
EMN
$8.29B
| $20.7M | ﹤0.01% |
236,714
-100
| -0% | -$8.69K |
|
|
TIBX
1109
DELISTED
TIBCO SOFTWARE INC
TIBX
| $20.6M | ﹤0.01% |
1,021,880
-1,808,700
| -64% | -$36.1M |
|
1110
Church & Dwight Co
CHD
$24B
| $20.5M | ﹤0.01% |
586,314
-34,186
| -6% | -$1.18M |
|
|
OB
1111
DELISTED
Onebeacon Insurance Group Ltd
OB
| $20.4M | ﹤0.01% |
1,315,245
| – | – |
|
1112
Avis
CAR
$4.93B
| $20.2M | ﹤0.01% |
337,800
+26,200
| +8% | +$1.44M |
|
|
CMCM
1113
Cheetah Mobile
CMCM
$93.7M
| $20.1M | ﹤0.01% |
+189,447
| New | +$17M |
|
|
CDR
1114
DELISTED
Cedar Realty Trust, Inc
CDR
| $20.1M | ﹤0.01% |
487,636
+47,257
| +11% | +$1.91M |
|
|
ESIO
1115
DELISTED
Electro Scientific Industries
ESIO
| $20.1M | ﹤0.01% |
2,949,260
+22,450
| +0.8% | +$179K |
|
1116
Community Health Systems
CYH
$410M
| $20M | ﹤0.01% |
534,623
+489,808
| +1,093% | +$16.3M |
|
1117
National Bank Holdings
NBHC
$1.92B
| $20M | ﹤0.01% |
1,005,330
+65,650
| +7% | +$1.28M |
|
|
IPG
1118
DELISTED
Interpublic Group of Companies
IPG
| $20M | ﹤0.01% |
1,026,419
-400
| -0% | -$7.26K |
|
|
OPWR
1119
DELISTED
OPOWER INC COM STK (DE)
OPWR
| $19.9M | ﹤0.01% |
+1,057,740
| New | +$19.7M |
|
1120
Markel Group
MKL
$22.8B
| $19.9M | ﹤0.01% |
30,311
-102,155
| -77% | -$64.4M |
|
1121
Allot
ALLT
$377M
| $19.9M | ﹤0.01% |
1,521,980
-5,750
| -0.4% | -$75.3K |
|
1122
Insteel Industries
IIIN
$635M
| $19.6M | ﹤0.01% |
998,330
+6,500
| +0.7% | +$131K |
|
|
AXE
1123
DELISTED
Anixter International Inc
AXE
| $19.6M | ﹤0.01% |
196,000
+28,200
| +17% | +$2.78M |
|
1124
Molson Coors Class B
TAP
$7.75B
| $19.6M | ﹤0.01% |
264,028
+15,520
| +6% | +$1,000K |
|
|
TAHO
1125
DELISTED
Tahoe Resources Inc
TAHO
| $19.6M | ﹤0.01% |
745,663
+8,580
| +1% | +$192K |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.